keyword
https://read.qxmd.com/read/38723371/mink1-deficiency-stimulates-nucleus-pulposus-cell-pyroptosis-and-exacerbates-intervertebral-disc-degeneration
#21
JOURNAL ARTICLE
Kunyu Zhan, Keying Zhu, Bingyan Gu, Sai Yao, Fangda Fu, Hanbing Zeng, Kun Tian, Weifeng Ji, Hongting Jin, Peijian Tong, Chengliang Wu, Ming Yue, Hongfeng Ruan
Intervertebral disc (IVD) degeneration, induced by aging and irregular mechanical strain, is highly prevalent in the elderly population, serving as a leading cause of chronic low back pain and disability. Evolving evidence has revealed the involvement of nucleus pulposus (NP) pyroptosis in the pathogenesis of IVD degeneration, while the precise regulatory mechanisms of NP pyroptosis remain obscure. Misshapen/Nck-interacting kinase (NIK)-related kinase 1 (MINK1), a serine-threonine protein kinase, has the potential to modulate the activation of NLRP3 inflammasome, indicating its pivotal role in governing pyroptosis...
May 8, 2024: International Immunopharmacology
https://read.qxmd.com/read/38722328/low-intensity-vestibular-noise-stimulation-improves-postural-symptoms-in-progressive-supranuclear-palsy
#22
JOURNAL ARTICLE
Max Wuehr, Daniela Peto, Urban M Fietzek, Sabrina Katzdobler, Georg Nübling, Mirlind Zaganjori, Matthias Brendel, Johannes Levin, Günter U Höglinger, Andreas Zwergal
BACKGROUND: Postural imbalance and falls are an early disabling symptom in patients with progressive supranuclear palsy (PSP) of multifactorial origin that may involve abnormal vestibulospinal reflexes. Low-intensity noisy galvanic vestibular stimulation (nGVS) is a non-invasive treatment to normalize deficient vestibular function and attenuate imbalance in Parkinson's disease. The presumed therapeutic mode of nGVS is stochastic resonance (SR), a mechanism by which weak sensory noise stimulation can enhance sensory information processing...
May 9, 2024: Journal of Neurology
https://read.qxmd.com/read/38721781/disentangling-bradykinesia-and-rigidity-in-parkinson-disease-evidence-from-short-and-long-term-subthalamic-nucleus-deep-brain-stimulation
#23
JOURNAL ARTICLE
Alessandro Zampogna, Antonio Suppa, Francesco Bove, Francesco Cavallieri, Anna Castrioto, Sara Meoni, Pierre Pelissier, Emmanuelle Schmitt, Stephan Chabardes, Valerie Fraix, Elena Moro
OBJECTIVE: Bradykinesia and rigidity are considered closely related motor signs in Parkinson disease (PD), but recent neurophysiological findings suggest distinct pathophysiological mechanisms. This study aims to examine and compare longitudinal changes in bradykinesia and rigidity in PD patients treated with bilateral subthalamic nucleus deep brain stimulation (STN-DBS). METHODS: In this retrospective cohort study, the clinical progression of appendicular and axial bradykinesia and rigidity was assessed up to 15 years after STN-DBS in the best treatment conditions (ON medication and ON stimulation)...
May 9, 2024: Annals of Neurology
https://read.qxmd.com/read/38721126/clinical-outcomes-after-use-of-checkpoint-inhibitor-immunotherapies-in-people-with-multiple-sclerosis
#24
JOURNAL ARTICLE
Alyssa N Nylander, William Rowles, Shane Poole, Riley Bove
BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a novel class of agents approved for the treatment of several cancers and progressive multifocal leukoencephalopathy (PML). However, due to the risk of autoimmune side effects, their use in people with autoimmune diseases such as multiple sclerosis (MS) has been limited. OBJECTIVE: To characterize outcomes in a cohort of adults with MS who received ICIs. METHODS: A single-center retrospective review of medical record data was performed for people with MS treated with ICIs...
2024: Multiple Sclerosis Journal—Experimental, Translational and Clinical
https://read.qxmd.com/read/38720903/research-progress-of-autoimmune-diseases-based-on-induced-pluripotent-stem-cells
#25
REVIEW
Rutong Ren, Jinhe Jiang, Xinxin Li, Guirong Zhang
Autoimmune diseases can damage specific or multiple organs and tissues, influence the quality of life, and even cause disability and death. A 'disease in a dish' can be developed based on patients-derived induced pluripotent stem cells (iPSCs) and iPSCs-derived disease-relevant cell types to provide a platform for pathogenesis research, phenotypical assays, cell therapy, and drug discovery. With rapid progress in molecular biology research methods including genome-sequencing technology, epigenetic analysis, '-omics' analysis and organoid technology, large amount of data represents an opportunity to help in gaining an in-depth understanding of pathological mechanisms and developing novel therapeutic strategies for these diseases...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38720763/leveraging-anfis-with-adam-and-pso-optimizers-for-parkinson-s-disease
#26
JOURNAL ARTICLE
Akram Pasha, Syed Thouheed Ahmed, Ranjith Kumar Painam, Sandeep Kumar Mathivanan, Karthikeyan P, Saurav Mallik, Hong Qin
Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by motor deficits, including tremor, rigidity, bradykinesia, and postural instability. According to the World Health Organization, about 1 % of the global population has been diagnosed with PD, and this figure is expected to double by 2040. Early and accurate diagnosis of PD is critical to slowing down the progression of the disease and reducing long-term disability. Due to the complexity of the disease, it is difficult to accurately diagnose it using traditional clinical tests...
May 15, 2024: Heliyon
https://read.qxmd.com/read/38719983/discovery-of-a-brain-penetrant-small-molecule-antagonist-targeting-lpa1-receptors-to-reduce-neuroinflammation-and-promote-remyelination-in-multiple-sclerosis
#27
JOURNAL ARTICLE
Michael M Poon, Kym I Lorrain, Karin J Stebbins, Geraldine C Edu, Alexander R Broadhead, Ariana O Lorenzana, Bryanna E Paulson, Christopher S Baccei, Jeffrey R Roppe, Thomas O Schrader, Lino J Valdez, Yifeng Xiong, Austin C Chen, Daniel S Lorrain
Multiple sclerosis (MS) is a chronic neurological disease characterized by inflammatory demyelination that disrupts neuronal transmission resulting in neurodegeneration progressive disability. While current treatments focus on immunosuppression to limit inflammation and further myelin loss, no approved therapies effectively promote remyelination to mitigate the progressive disability associated with chronic demyelination. Lysophosphatidic acid (LPA) is a pro-inflammatory lipid that is upregulated in MS patient plasma and cerebrospinal fluid (CSF)...
May 8, 2024: Scientific Reports
https://read.qxmd.com/read/38719433/active-and-non-active-progression-independent-of-relapse-activity-within-the-first-20-years-of-relapsing-multiple-sclerosis
#28
JOURNAL ARTICLE
Adil Maarouf, Jan Patrick Stellmann, Audrey Rico, Clemence Boutiere, Sarah Demortiere, Pierre Durozard, Wafaa Zaaraoui, Jean-Philippe Ranjeva, Jean Pelletier, Bertrand Audoin
BACKGROUND: Progression independent of relapse activity (PIRA) has been described since the early stage of relapsing multiple sclerosis (RMS). However, little is known about the relation between PIRA and inflammatory activity that is particularly important at this stage of the disease. METHOD: We included 110 patients in a prospective study within 18 months of RMS onset. MRI examinations and clinical visits were scheduled on the same day for months 0, 6, 12, 24, 36, 60, 84, 120, 180 and 240...
May 6, 2024: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/38719072/total-shoulder-arthroplasty-for-glenohumeral-arthritis-associated-with-posterior-glenoid-bone-loss-midterm-results-of-an-all-polyethylene-posteriorly-augmented-stepped-glenoid-component
#29
JOURNAL ARTICLE
Dennis DeBernardis, David Donnelly, Aditya Bahel, Paul Favorito
BACKGROUND: The purpose of this study is to report the minimum 5-year clinical and radiographic outcomes of patients undergoing anatomic total shoulder arthroplasty (aTSA) with a posteriorly augmented glenoid component. METHODS: Thirty-five shoulders with minimum 5-year follow-up underwent aTSA using a posteriorly augmented glenoid component for the treatment of glenohumeral osteoarthritis with posterior glenoid bone loss. Clinical outcomes included range of motion (ROM), Visual Analog Scale (VAS) for pain, and patient reported outcomes scores (PROS)...
May 6, 2024: Journal of Shoulder and Elbow Surgery
https://read.qxmd.com/read/38718781/quality-of-life-analysis-in-patients-with-retinitis-pigmentosa
#30
JOURNAL ARTICLE
Audrey Humphries, Lee Bowman, Timothy Nguyen, Joshua So, Madison Duff, Sandeep Grover, Jinghua Chen
INTRODUCTION: Retinitis pigmentosa (RP) is a chronic progressive disease causing loss of visual acuity and ultimately blindness. This visual impairment can contribute to psychiatric comorbidity and worse overall quality of life (QOL). Our goal was to assess the relationship between the severity of disease for people with RP and QOL as it pertains to mental health, social support, disability resources, and financial factors. METHODS: This was a survey study conducted from June 2021 to February 2022 including 38 people with RP...
May 8, 2024: Ophthalmic Research
https://read.qxmd.com/read/38718750/familial-vs-sporadic-multiple-sclerosis-in-the-israeli-population-differences-in-ethnicity-distribution-and-disease-progression-with-anticipation-in-successive-generations
#31
JOURNAL ARTICLE
Netta Kugelman, Elsebeth Staun-Ram, Anat Volkovitz, Ofra Barnett-Griness, Lea Glass-Marmor, Ariel Miller
BACKGROUND: Multiple Sclerosis (MS) may cluster in families, an entity known as familial MS (FMS), possibly due to aggregation of genetic and environmental factors. Though previous studies have characterized FMS in different populations, no study to the best of our knowledge has yet characterized FMS in the unique Israeli population, which is comprised of relatively endogamous ethnicities. Our goal in this study was to compare demographic and clinical characteristics between FMS and sporadic MS (SMS), and to search for intra-familial patterns...
April 3, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38718748/neda-3-achievement-in-early-highly-active-relapsing-remitting-multiple-sclerosis-patients-treated-with-ocrelizumab-or-natalizumab
#32
JOURNAL ARTICLE
Elisabetta Signoriello, Alessio Signori, Giacomo Lus, Giuseppe Romano, Girolama Alessandra Marfia, Doriana Landi, Francesca Napoli, Emanuele D' Amico, Aurora Zanghí, Paola Sofia Di Filippo, Daniele Caliendo, Antonio Carotenuto, Antonio Luca Spiezia, Roberta Fantozzi, Diego Centonze, Matteo Lucchini, Massimiliano Mirabella, Eleonora Cocco, Jessica Frau, Giorgia Teresa Maniscalco, Maria Elena Di Battista, Matteo Foschi, Andrea Surcinelli, Simona Bonavita, Gianmarco Abbadessa, Livia Pasquali, Maria Di Gregorio, Maria Teresa Ferrò, Maria Pia Sormani, Irene Schiavetti
BACKGROUND: in the early stages of Multiple Sclerosis (MS), initiating high-efficacy disease-modifying therapy (HE DMTs) may represent an optimal strategy for delaying neurological damage and long-term disease progression, especially in highly active MS patients (HAMS). Natalizumab (NAT) and Ocrelizumab (OCR) are recognized as HE DMTs with significant anti-inflammatory effects. This study investigates NEDA-3 achievement in treatment-naïve HAMS patients receiving NAT or OCR over three years...
April 6, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38718660/cathelicidin-bf-regulates-the-ampk-sirt1-nf-%C3%AE%C2%BAb-pathway-to-ameliorate-murine-osteoarthritis-in-vitro-and-in-vivo-studie
#33
JOURNAL ARTICLE
Hao Zhou, Linfang Zou, Hui Ren, Zhenyu Shen, Yuanqu Lin, Haikang Cai, Jingdong Zhang
Osteoarthritis (OA) is a chronic degenerative disease with a significant prevalence that causes cartilage damage and can lead to disability. The main factors contributing to the onset and progression of OA include inflammation and degeneration of the extracellular matrix. Cathelicidin-BF (BF-30), a natural peptide derived from Bungarus fasciatus venom, has shown multiple important pharmacological effects. However, the action mechanism of BF-30 in OA treatment remains to be elucidated. In this research, X-ray and Safranin O staining were employed to evaluate the imageology and histomorphology differences in the knee joints of mice in vivo...
May 7, 2024: International Immunopharmacology
https://read.qxmd.com/read/38718039/mume-fructus-reduces-interleukin-1-beta-induced-cartilage-degradation-via-mapk-downregulation-in-rat-articular-chondrocytes
#34
JOURNAL ARTICLE
Doo Ri Park, Bo Ram Choi, Changhwan Yeo, Jee Eun Yoon, Eun Young Hong, Seung Ho Baek, Yoon Jae Lee, In-Hyuk Ha
Osteoarthritis is the most prevalent type of degenerative arthritis. It is characterized by persistent pain, joint dysfunction, and physical disability. Pain relief and inflammation control are prioritised during osteoarthritis treatment Mume Fructus (Omae), a fumigated product of the Prunus mume fruit, is used as a traditional medicine in several Asian countries. However, its therapeutic mechanism of action and effects on osteoarthritis and articular chondrocytes remain unknown. In this study, we analyzed the anti-osteoarthritis and articular regenerative effects of Mume Fructus extract on rat chondrocytes...
2024: PloS One
https://read.qxmd.com/read/38717877/development-of-a-motion-based-video-game-for-postural-training-a-feasibility-study-on-older-adults-with-adult-degenerative-scoliosis
#35
JOURNAL ARTICLE
Frances K W Wan, Alex T H Mak, Claire W Y Chung, Joanne Y W Yip
Forward sagittal alignment affects physical performance, is associated with pain and impacts the health-related quality of life of the elderly. Interventions that help seniors to improve sagittal balance are needed to inhibit the progression of pain and disability. A motion-sensing video game (active game) is developed in this study to monitor sitting and standing postures in real-time and facilitate the postural learning process by using optical sensors to measure body movement and a video game to provide visual feedback...
May 8, 2024: IEEE Transactions on Neural Systems and Rehabilitation Engineering
https://read.qxmd.com/read/38717246/occupational-nerve-injuries
#36
REVIEW
Sandra L Hearn, Shawn P Jorgensen, Joelle M Gabet, Gregory T Carter
Occupational nerve injuries span a broad array of pathologies and contribute toward functional limitation, disability, and economic impact. Early and accurate recognition, treatment, and management of workplace factors rely on a thorough understanding of the anatomic and biomechanical factors that drive nerve injury. This review explores the interplay between anatomy, biomechanics, and nerve pathology common to occupational nerve injury and provides the treating physician with a rational, evidence-based approach to diagnosis and to occupational aspects of management...
May 8, 2024: Muscle & Nerve
https://read.qxmd.com/read/38715962/emerging-insights-into-cuproptosis-and-copper-metabolism-implications-for-age-related-diseases-and-potential-therapeutic-strategies
#37
REVIEW
Haohui Fan, Kun Wang, Xiaofang Zhao, Bei Song, Tianci Yao, Ting Liu, Guangyu Gao, Weilin Lu, Chengyun Liu
The expanding geriatric population, whose predisposition toward disabling morbidities and age-related diseases (ARD) is well-documented, has become a paramount social issue, exerting an onerous burden on both the healthcare industry and wider society. ARD manifest as the progressive deterioration of bodily tissues and organs, eventually resulting in the failure of these vital components. At present, no efficacious measures exist to hinder the onset of ARD. Copper, an essential trace element, is involved in a wide range of physiological processes across different cell types...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38715316/-the-burden-is-very-much-on-yourself-a-qualitative-study-to-understand-the-illness-and-treatment-burden-of-hearing-loss-across-the-life-course
#38
JOURNAL ARTICLE
Sian K Smith, Helen Pryce, Georgina Burns O'Connell, Saira Hussain, Rachel Shaw, Jean Straus
INTRODUCTION: Hearing loss is a chronic health condition that rises sharply with age. The way people respond to and cope with health conditions is influenced by their capacity to perform illness and treatment-related work. The aim was to explore the cumulative burdens of living with hearing loss and the resources mobilised to ease the burdens. METHODS: A qualitative design was used with semi-structured interviews (online or in-person) with participants recruited through audiology services and nonclinical services, such as lip-reading classes...
June 2024: Health Expectations: An International Journal of Public Participation in Health Care and Health Policy
https://read.qxmd.com/read/38715245/alemtuzumab-treatment-for-multiple-sclerosis-in-austria-an-observational-long-term-outcome-study
#39
JOURNAL ARTICLE
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
BACKGROUND/OBJECTIVE: Observational real-world study to analyze the clinical effects of alemtuzumab (ALEM) and subsequent disease-modifying therapy (DMT) usage in multiple sclerosis (MS). METHODS: Data retrieved from the Austrian MS treatment registry (AMSTR) included baseline (BL) characteristics (at ALEM start), annualized relapse rate (ARR), 6-month confirmed progression independent of relapse activity (PIRA; ≥ 0.5-point Expanded Disability Status Scale (EDSS) score increase), 6-month confirmed disability improvement (CDI; ≥ 0...
May 7, 2024: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/38715244/polygenic-liability-for-anxiety-in-association-with-comorbid-anxiety-in-multiple-sclerosis
#40
JOURNAL ARTICLE
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Amber Salter, Yi Lu, Charles N Bernstein, James M Bolton, Gary Cutter, John D Fisk, Joel Gelernter, Lesley A Graff, Sara Hägg, Carol A Hitchon, Daniel F Levey, Fred D Lublin, Kyla A McKay, Scott Patten, Amit Patki, Murray B Stein, Hemant K Tiwari, Jerry S Wolinsky, Ruth A Marrie
OBJECTIVE: Comorbid anxiety occurs often in MS and is associated with disability progression. Polygenic scores offer a possible means of anxiety risk prediction but often have not been validated outside the original discovery population. We aimed to investigate the association between the Generalized Anxiety Disorder 2-item scale polygenic score with anxiety in MS. METHODS: Using a case-control design, participants from Canadian, UK Biobank, and United States cohorts were grouped into cases (MS/comorbid anxiety) or controls (MS/no anxiety, anxiety/no immune disease or healthy)...
May 7, 2024: Annals of Clinical and Translational Neurology
keyword
keyword
162373
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.